Lynn Seely
2018
In 2018, Lynn Seely earned a total compensation of $4.4M as Principal Executive Officer at Myovant Sciences Ltd., a 64% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,360 |
|---|---|
| Option Awards | $3,607,897 |
| Salary | $557,000 |
| Other | $2,045 |
| Total | $4,434,302 |
Seely received $3.6M in option awards, accounting for 81% of the total pay in 2018.
Seely also received $267.4K in non-equity incentive plan, $557K in salary and $2K in other compensation.
Rankings
In 2018, Lynn Seely's compensation ranked 2,404th out of 14,244 executives tracked by ExecPay. In other words, Seely earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,404 out of 14,244 | 83rd |
Division Manufacturing | 882 out of 5,759 | 85th |
Major group Chemicals And Allied Products | 298 out of 2,122 | 86th |
Industry group Drugs | 242 out of 1,811 | 87th |
Industry Pharmaceutical Preparations | 187 out of 1,385 | 87th |
Source: SEC filing on July 25, 2019.
Seely's colleagues
We found four more compensation records of executives who worked with Lynn Seely at Myovant Sciences Ltd. in 2018.